Skip to main content

Table 1 Baseline characteristics of the included patients

From: Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study

ID

Age

PSA

16-needle biopsy pathology

PSA1

PSA2

f/t PSA

0009315

68

11.30

4.97

21.63

BPH

0009901

60

9.81

10.67

19.82

BPH

0009750

74

14.17

10.99

19.09

BPH

SH-CL

57

7.96

7.76

8.88

BPH

0009973

70

23.32

15.20

15.75

BPH

0010268

65

14.38

9.18

9.52

BPH

0009994

56

11.39

8.35

14.65

BPH

0010622

65

10.24

9.26

13.61

BPH

SH-ZRM

62

7.70

6.81

23.66

BPH

0010253

56

13.11

13.88

21.13

PIN

0010244

69

7.29

6.70

8.74

PIN

0010247

60

7.11

5.64

22.06

PIN

0009552

69

> 1000

1000.00

9.60

PCa, GS = 3 + 3 = 6

0009330

79

121.00

151.00

12.45

PCa, GS = 3 + 3 = 6

SH-WSG

70

7.98

8.68

11.11

PCa, GS = 3 + 3 = 6

SH-ZHJ

73

8.41

3.85

18.72

PCa, GS = 3 + 3 = 6

0009245

73

80.57

76.09

22.67

PCa, GS = 3 + 4 = 7

0010245

65

15.13

14.60

8.15

PCa, GS = 4 + 3 = 7

SH-LHY

74

7.82

6.70

26.27

PCa, GS = 4 + 3 = 7

0009210

63

486.00

343.80

–

PCa, GS = 3 + 5 = 8

0010753

77

14.10

12.64

23.82

PCa, GS = 4 + 4 = 8

0009675

74

13.90

11.59

5.65

PCa, GS = 4 + 4 = 8

SH-JBL

64

424.60

555.01

–

PCa, GS = 4 + 4 = 8

SH-ZYX

73

33.07

29.76

21.57

PCa, GS = 4 + 5 = 9

0009884

70

260.50

236.28

–

PCa, GS = 4 + 5 = 9

0009834

69

> 1000

56.83

–

PCa, GS = 4 + 5 = 9

0009551

73

819.00

602.99

–

PCa, GS = 4 + 5 = 9

0009476

79

> 1000

1000.00

–

PCa, GS = 5 + 4 = 9